Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (AMD3100)

This study has been withdrawn prior to enrollment.
(Never Activated)
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01353937
First received: May 12, 2011
Last updated: March 2, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)